
Rozilitrex Capsule 100 mg (Entrectinib)
100mg
Hard capsule · Prescription medication
Roche Korea Co., Ltd.
Entrectinib is an anticancer active ingredient used in the treatment of cancers with specific genetic mutations.
MFDS ingredient code M278562
Entrectinib belongs to a class of targeted anticancer agents that specifically target certain genetic mutations within cancer cells. This ingredient is used to inhibit the growth and proliferation of cancer cells.
Entrectinib works by blocking the activity of specific proteins within cancer cells, preventing them from growing and spreading. This can slow down or halt the progression of cancer.
Approved uses differ by product. Check each product's information for its actual use.
Entrectinib is a targeted anticancer agent specialized for specific genetic mutations, and unlike conventional chemotherapy agents, it tends to cause less damage to normal cells. It also penetrates well into the brain, making it effective for the treatment of brain metastases.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.